Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Fundsmith Equity Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+9.6%
Annualized+14.1%
Digest Analysis
Quick Take
"The fund targets companies with sustainable competitive advantages and high returns on capital, maintaining significant exposure to healthcare and consumer staples. Strong performance from Novo Nordisk and Microsoft offset weakness in Nike and Visa."
Executive Summary
Fundsmith Equity Fund delivered a 9.6% return in Q1 2024, outperforming global equities. The fund maintains its concentrated approach with 28 holdings focused on high-quality businesses that generate sustainable high returns on capital without leverage. The portfolio is globally diversified with 68.9% US exposure, concentrated in healthcare, consumer staples, and technology sectors. Top contributors included Novo Nordisk, Microsoft, McCormick, Alphabet, and Amadeus, while detractors were IDEXX, Brown-Forman, Nike, Visa, and L'Oréal. The fund began building a new undisclosed position during the quarter. With a median market cap of £103.7bn and 89% active share, the strategy targets businesses with difficult-to-replicate advantages, resilience to technological change, and attractive valuations. The fund maintains its disciplined approach of avoiding derivatives, hedging, short-term trading, and leverage while focusing on long-term wealth creation through ownership of exceptional global businesses.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
72%
CautiousHigh
High Conviction (72%)
The fund demonstrates high conviction through its concentrated 28-position portfolio with 89% active share and clear investment criteria. Named top holdings include Microsoft, Novo Nordisk, and Meta Platforms. The disciplined approach of avoiding derivatives and maintaining long-term focus indicates strong conviction, though the absence of position sizing details and hedged investment criteria language prevents a higher score.
Growth Outlook
0%
BearishBullish
Bearish (0%)
The factsheet provides no explicit market outlook commentary. It focuses purely on performance data and portfolio composition without expressing views on market conditions or future opportunities.
Risk Appetite
10%
DefensiveAggressive
Defensive (10%)
The fund maintains a fully invested stance with only 2.4% cash and began building a new position, indicating slight risk-on positioning. However, the conservative quality-focused approach and lack of leverage suggests measured risk appetite.
Capital Deployment
15%
De-riskingDeploying
De-risking (15%)
The fund began building a new position during the quarter, indicating modest deployment activity. With only 2.4% cash and no specific cash level changes disclosed, this represents limited but positive deployment activity.
Forward Guidance
0%
CautiousExpansionary
Cautious (0%)
No forward guidance or intended actions are provided beyond the mention of building a new undisclosed position. The factsheet is purely retrospective in nature.
Language Signal
0%
BearishBullish
Bearish (0%)
The language is entirely neutral and factual, focusing on performance attribution and portfolio characteristics without directional sentiment indicators.
Perceived Risk
25%
Low RiskElevated
Low Risk (25%)
Standard risk disclosures mention currency exposure and concentration risk, but no specific market or economic risks are highlighted. The risk discussion is limited to standard regulatory language about volatility and loss potential.
Opportunity Density
45%
ScarceAbundant
Selective (45%)
The initiation of a new position suggests some opportunities exist, but the concentrated approach and stringent investment criteria imply selectivity. No commentary on the broader opportunity set is provided.
Time Horizon
75%
Short-TermLong-Term
Decade+ (75%)
The fund explicitly states it will be a long-term investor and will not adopt short-term trading strategies. The investment approach emphasizes holding chosen stocks for the long term, with shares viewed as long-term investments of at least 5 years, indicating a multi-year investment horizon.